abstract |
The invention relates to 6-substituted isoquinoline and isoquinoline derivatives of the formula (I) n nuseful for the treatment and/or prevention of diseases associated with Rho-kinase and/or Rho-kinase mediated phosphorylation of myosin light chain phosphatase, and compositions containing such compounds. |